Dr Najihah Abu Bakar

Procedures Performed:

• Chemotherapy administration
• Targeted therapy and Immunotherapy administration
• Radiotherapy (IMRT, VMAT, 3D, 2D) including stereotactic technique and

  brachytherapy

•  Special interest in breast, colorectal, head and neck and geriatric oncology 

Undergraduate:

• MB, BCh, BAO (National University of Ireland, Ireland) 2010

Post Graduate Qualifications:

• Master of Clinical Oncology (University of Malaya, Malaysia) 2020 

Clinical Training:

• Clinical Oncologist (Dec 2020 – 14 Feb 2022) Hospital Kuala Lumpur

• State of Perak Oncology Head of Service, Head of Radiotherapy and Oncology Unit (15 Feb 2022 – 5 Jun 2023) Hospital Raja Permaisuri Bainun Ipoh, Perak

• Clinical Oncologist (6 Jun 2023 – present) Hospital Kuala Lumpur

Memberships & Associations:

• Mal1. Malaysian Oncological Society
• College of Oncologists, Academy of Medicine (AM)
• European Society of Medical Oncology (ESMO)
• European Society of Radiotherapy and Oncology (ESTRO)

Awards:

• Anugerah Perkhidmatan Cemerlang 2016, Ministry of Health, Malaysia
• Setting up oncology service in the state of Perak at Hospital Raja Permaisuri Bainun, Ipoh (2022)

• Anugerah Perkhidmatan Cemerlang 2023, Ministry of Health, Malaysia.

Media & Publications:

1. Efficacy and Safety of Pazopanib in Advanced Renal Cell Carcinoma treated at University Malaya Medical Centre, Advances in Modern Oncology Research, Vol 3 No 6
2. YO Case Presentations ESMO Asia Congress 2019: Squamous cell carcinoma of renal parenchyma in a 30-year-old female with renal calculi.
3. Final Year Master of Clinical Oncology thesis November 2020 - Prostate Radiotherapy Plan Quality Assessment Using Data Envelopment Analysis: A Comparative Study
4. Poster presentation ASCOMOS 2021 entitled ‘Radiation Recall Dermatitis with Palbociclib
5. Poster presentation ASCOMOS 2023 entitled ‘Challenges to Manage AlpelisibInduced Hyperglycaemia in Malaysia Government Hospital
6. Co-author for Poster presentation in ASCOMOS 2024 entitled ‘Ghost Cell Odontegenic Carcinoma Arising from Recurrent Dentinogenic Ghost Cell Tumor
7. Co-author for Poster presentation in Lung Cancer Symposium 2025 entitled  Anterior mediastinal mass with raised beta HCG- germ cell tumor or lung cancer’